OOIR: Observatory of International Research

Papers

(The TQCC of Thrombosis Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	61
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	56
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	46
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	36
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	31
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	27
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	25
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	25
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	24
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	24
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	24
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	22
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	21
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study	20
Comparison between canine and porcine models of chronic deep venous thrombosis	20
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes	20
Efficacy and safety of direct oral anticoagulants in pediatric congenital and acquired heart disease: a systematic review and meta-analysis of randomized controlled trials	20
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	19
Cerebral venous sinus thrombosis in a family with protein S deficiency: genetic analysis and phenotypic characterization	19
Urinary 11-dehydrothromboxane B2 as a dynamic biomarker of atherosclerotic thrombotic risk and its association with plaque instability	19
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	19
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	17
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study	17
Efficacy, safety, and influencing factors of AngioJet mechanical thrombectomy versus catheter-directed thrombolysis in the treatment of acute lower limb deep vein thrombosis	16
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	15

The interaction of fibrinolysis and the complement system in patients with acute pulmonary embolism, treated with ultrasound-assisted catheter-directed thrombolysis	15
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance	14
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis	14
High thrombotic burden in severe Chinese wAIHA patients: a single-center retrospective study	14
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on	14
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis	14
Recurrent arterial and venous thrombosis in a 39-year-old male with Factor V Leiden syndrome and aneurysmal disease: a case report and review of the literature	14
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial	14
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism	14
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	13
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant	13
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis	13
Exploring the genetic basis between inflammatory bowel disease and venous thromboembolism	13
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults	13
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods	12
Incidence, outcomes, and risk factors of Heparin-induced thrombocytopenia in patients undergoing primary and revision knee arthroplasty	12
Plasma PF4 is a reliable biomarker of platelet reactivity and predictive of bleeding risk in DAPT patients undergoing cardiac surgery	12
Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension	12
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency	12
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	12
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	12
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study	11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o	11
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban	11
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage	11
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study	11
A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan	11
Abnormal fibrin clot properties as a potential mechanism of recurrent arterial thrombosis in a young woman: a 10-year follow-up case report	11
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI	11
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)	11
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	11
A scoping review of factors affecting activated clotting time measurement results	11
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection	11
Clinical features and risk factors for poor prognosis in malignant tumor patients with pulmonary embolism: a case control study	11
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation	11
Risk factor analysis and development of nomogram prediction model for central venous catheter-related thrombosis in burn patients: a retrospective observational study	11
Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and systemic immune-inflammation index as predictors of venous thromboembolism in patients with diffuse large B-cell lymphoma	10
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	10
Process and outcome evaluation of a regional pulmonary embolism response team	10
Research advances on platelet glycoprotein VI in ischemic stroke	10
Bleeding and thrombotic events in patients with heparin-induced thrombocytopenia: a two-decade single-center experience in Thailand	10
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation	10
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism	10
Cancer-Associated Thrombosis (CAT); mechanisms and treatment options	10
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	10
An integrative analysis of genetic factors reveals dysregulation of cytokines, immune signaling, and T cell activity as the underlying immune mechanisms in autoimmune immune thrombocytopenia	10
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study	10
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	9
Practical approach to thrombocytopenia in patients with sepsis: a narrative review	9
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	9

Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials	9
Causes of death after first time venous thromboembolism	9
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	9
Timing of disseminated intravascular coagulation onset is associated with development of persistent inflammation, immunosuppression, and catabolism syndrome in critically ill patients	9
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy	9
Perioperative inflammatory and coagulation biomarkers for predicting venous thromboembolism after lower limb fracture surgery	8
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	8
Acquired factor V inhibitor masked by triple antithrombotic therapy presenting as severe gastrointestinal bleeding: a case report	8
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	8
A comparative study on early prediction of venous thromboembolism in patients with traumatic brain injury by machine learning model	8
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	8
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	8
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	8
A nomogram for individualized prediction of calf muscular venous thrombosis in patients with acute ischemic stroke: a retrospective study	8
Escalating doses of intravenous APAC demonstrate antithrombotic effect in pigs	8
Outcomes in patients with atrial fibrillation with and without heart failure on oral anticoagulants: a multicenter retrospective cohort study	8
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	8
Emerging strategies in venous thromboembolism: a narrative review of pharmacological innovations	7
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study	7
Predictors of pulmonary embolism in hospitalized patients with COVID-19	7
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	7
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	7
Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 2025	7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization	7
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	7
Acquired circulating heparin-like anticoagulants associated with multiple myeloma: three cases reports and literature review	7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	6
“Y appearance” infarction: caused by essential thrombocythemia	6
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study	6
Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report	6
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic	6
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	6
Development and temporal validation of a clinical prediction score for deep vein thrombosis following femoral neck fracture surgery: a retrospective cohort study with decision curve analysis	6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19	6
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4	6
Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene	6
Venous thromboembolic disease in admitted blunt trauma patients: what matters?	6
The effect of neutrophil extracellular traps in venous thrombosis	6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study	6
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re	6
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	6
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	5
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing	5
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study	5
Correction: Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants	5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study	5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia	5
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study	5
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial	5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry	5
Right heart thrombus in transit and peripherally inserted central catheters	5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study	5
Lemierre’s syndrome complicating deep neck abscess: a case report	5
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study	5
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	5
Fibrinogen-to-albumin ratio and risk of thrombotic diseases incidence	5
National trends in venous thromboembolism-related mortality among pancreatic cancer patients in the United States, 1999–2020	5
Clinical characteristics of COVID-19 associated vasculopathic diseases	5
Single-leaflet reconstruction surgery for severe chronic lower limb venous insufficiency caused by post-thrombotic syndrome: a case report and literature review	5
Popliteal vein aneurysm presenting in a patient with cerebral infarction and patent foramen ovale: a rare case with complex thrombotic events	5
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase	5
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	5
Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants	5
Pooled estimate of anticoagulation control with warfarin therapy among adult patients in Ethiopia: a systematic review and meta-analysis	5
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study	5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden	5
Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database	5
Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis	5
Time series differences in coagulopathy in mechanically ventilated COVID-19 and bacterial pneumonia patients: a nationwide observational study in Japan	5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	5